The Susan G. Komen for the Cure® Advocacy Alliance (KAA) is the non-partisan voice for over 2.5 million breast cancers survivors and the people who love them. Our mission is to translate the Komen promise to end breast cancer forever into action at all levels of government to discover and deliver the cures.
Cancer Treatment Fairness Act
2013 marks the second year in a row, Komen and many other organizations are fighting to have equal coverage for cancer patients who require life-saving oral anti-cancer meds. We are so excited to announce that Former State Senate President, Ken Pruitt, and the P5 Group have offered their services to Komen pro bono and are lobbying on our behalf! Representative Debbie Mayfield and Senator Lizbeth Benacquisto are sponsoring the Cancer Treatment Fairness Act. Much of the success we have had so far with this bill is owed to the group and we want to give them a big thank you for taking this on. We feel confident that Florida cancer patients are in good hands with this group and cannot wait to see what this legislative session brings!
Intravenous/infused anti-cancer medications are generally covered under a health plan's medical benefit which usually means the patient has a small co-pay, much like going to the doctor’s office. Orally-administered anti-cancer medications, which are being prescribed much more frequently than before, are usually covered under a prescription plan; requiring patients to pay higher co-pays, sometimes resulting in thousands of dollars each month. This disparity restricts patient access to life-saving oral cancer therapies. We believe that insurance companies should cover oral anti-cancer medications at a rate no less favorable than IV medications.
If you or a loved one has or is currently facing insurance issues in regards to oral anti-cancer meds, we want to know! Contact Stefanie at firstname.lastname@example.org.